Complimentary shipping over $150 · Join Aurevia One for member pricing · NuraProof early access is open
Real-World Evidence

Consent-based. De-identified. Clearly distinct from clinical trials.

With explicit user consent, de-identified NuraProof information may help AES study adherence, product use, reported tolerability and changes in selected wellness outcomes.

DisclosureObservational associations do not prove causation. Formal research requires appropriate governance. Clinical trials will not be represented as real-world app analysis.
What participants can rely on

Principles that govern AES real-world work.

  • Participation is optional. Research consent is separate from normal app use.
  • Users may withdraw where applicable.
  • Identifiable health information is not sold.
  • Commercial interests are disclosed.
  • Every project has a defined research question, analysis plan and publication commitment.
  • Ethics review is arranged where required.